Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis.

[1]  A. Paganini-Hill.  Estrogen replacement therapy and colorectal cancer risk in elderly women , 1999, Diseases of the colon and rectum.

[2]  F. Grodstein,et al.  Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis , 1999 .

[3]  G. Colditz,et al.  Postmenopausal Hormone Use and Risk for Colorectal Cancer and Adenoma , 1998, Annals of Internal Medicine.

[4]  C. la Vecchia,et al.  Hormone replacement therapy and risk of colon and rectal cancer. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[5]  R. Sandler,et al.  Reproductive history, use of exogenous hormones, and risk of colorectal adenomas. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  T. Louis,et al.  Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[7]  C. Schairer,et al.  Cancer incidence and mortality in women receiving estrogen and estrogen‐progestin replacement therapy—long‐term follow‐up of a Swedish cohort , 1996, International journal of cancer.

[8]  B. Hankey,et al.  Second cancers after adjuvant tamoxifen therapy for breast cancer. , 1996, Journal of the National Cancer Institute.

[9]  C. la Vecchia,et al.  Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer. , 1996, British Journal of Cancer.

[10]  K. Matthews,et al.  Prior to use of estrogen replacement therapy, are users healthier than nonusers? , 1996, American journal of epidemiology.

[11]  T. Sellers,et al.  Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. , 1995, American journal of public health.

[12]  P. Newcomb,et al.  Postmenopausal hormone use and risk of large-bowel cancer. , 1995, Journal of the National Cancer Institute.

[13]  T. Young,et al.  The association of reproductive and menstrual characteristics and colon and rectal cancer risk in Wisconsin women. , 1995, Annals of epidemiology.

[14]  H. Johansson,et al.  Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. , 1995, Journal of the National Cancer Institute.

[15]  R. Hoover,et al.  EVIDENCE OF A HEALTHY ESTROGEN USER SURVIVOR EFFECT , 1995, Epidemiology.

[16]  M. Thun,et al.  Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. , 1995, Journal of the National Cancer Institute.

[17]  H. Risch,et al.  Menopausal hormone use and colorectal cancer in Saskatchewan: a record linkage cohort study. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  G. McKeown-Eyssen.  Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  Mary L. Thomas,et al.  Estrogen receptor-mediated direct stimulation of colon cancer cell growth in vitro , 1994, Molecular and Cellular Endocrinology.

[20]  C. Paraskeva,et al.  Differential growth response to oestrogen of premalignant and malignant colonic cell lines. , 1994, Anticancer research.

[21]  M. Carcangiu.  Re: Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. , 1994, Journal of the National Cancer Institute.

[22]  S. Baylin,et al.  Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon , 1994, Nature Genetics.

[23]  C. Campagnoli,et al.  Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels. , 1993, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[24]  J. Neoptolemos,et al.  Oestrogen and progesterone receptors in colorectal cancer and human colonic cancer cell lines , 1993, The British journal of surgery.

[25]  T. Tong,et al.  Cancer statistics, 1993 , 1993, CA: a cancer journal for clinicians.

[26]  B. Boman,et al.  The effects of steroid hormones on a human colon cancer cell line in vitro. , 1992, Anticancer research.

[27]  S. Rosen,et al.  Stable expression of the human estrogen receptor in HeLa cells by infection: Effect of estrogen on cell proliferation and c-myc expression , 1991, Molecular and Cellular Endocrinology.

[28]  W. Willett,et al.  A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women. , 1991 .

[29]  A. Whittemore,et al.  Reproductive factors and colorectal cancer risk among Chinese females. , 1991, Cancer research.

[30]  D. Pezet,et al.  Status of sex steroid hormone receptors in large bowel cancer , 1991, Cancer.

[31]  S. Saez,et al.  Sex steroid and 1,25-dihydroxyvitamin D3 receptors in human colorectal adenocarcinoma and normal mucosa. , 1991, Cancer Research.

[32]  G. Everson,et al.  Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. , 1991, The Journal of clinical investigation.

[33]  J. Cauley,et al.  Prevalence and determinants of estrogen replacement therapy in elderly women , 1990, American journal of obstetrics and gynecology.

[34]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[35]  M. Pike,et al.  Reproductive factors and colon cancers. , 1990, British Journal of Cancer.

[36]  S. Shousha,et al.  Oestrogen receptors in colorectal carcinoma. , 1990, Journal of clinical pathology.

[37]  R. Hoover,et al.  Risk of cancer in women receiving hormone replacement therapy , 1989, International journal of cancer.

[38]  S. Furner,et al.  A case-control study of large bowel cancer and hormone exposure in women. , 1989, Cancer research.

[39]  M. Koch,et al.  The influence of parity and exogenous female hormones on the risk of colorectal cancer , 1989, International journal of cancer.

[40]  B. Henderson,et al.  A Prospective Study” , 2007 .

[41]  S Greenland,et al.  Quantitative methods in the review of epidemiologic literature. , 1987, Epidemiologic reviews.

[42]  J. Petrini,et al.  Acromegaly and colon cancer. , 1984, Annals of internal medicine.

[43]  J. Potter,et al.  Large bowel cancer in women in relation to reproductive and hormonal factors: a case-control study. , 1983, Journal of the National Cancer Institute.

[44]  C. Edman.  Estrogen Replacement Therapy , 1983 .

[45]  G. Parveen,et al.  Colonic polyps in patients with acromegaly. , 1982, Annals of internal medicine.

[46]  D. Barkla,et al.  Differential effects of oestrogenic hormones on cell proliferation in the colonic crypt epithelium and in colonic carcinomata of rats. , 1982, Anticancer research.

[47]  W. Chow,et al.  Incidence of cancer of the large bowel in women in relation to reproductive and hormonal factors. , 1981, Journal of the National Cancer Institute.

[48]  J. Potter,et al.  Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. , 1980, Journal of the National Cancer Institute.

[49]  E. Beckman,et al.  Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. , 1979, Obstetrics and gynecology.

[50]  W. Creasman,et al.  Effects of long-term estrogen replacement therapy. I. Metabolic effects. , 1979, American journal of obstetrics and gynecology.